Home >> Signaling Pathways >> Tyrosine Kinase

Tyrosine Kinase(酪氨酸激酶)

  1. Cat.No. 产品名称 Information
  2. GC32979 Chloropyramine hydrochloride

    盐酸氯吡胺

    Chloropyramine hydrochloride (Halopyramine) is a histamine receptor H1 antagonist and has anti-cholinergic, antispasmodic, and antiallergic effects.
  3. GC32968 FLT3-IN-1 FF-10101 is a novel irreversible FLT3 inhibitor with ic50 of 0.20 nM and 0.16 nM for FLT3 (WT) and FLT3(D835Y), respectively.
  4. GC32963 hVEGF-IN-1 hVEGF-IN-1, a quinazoline derivative, specifically binds to the G-rich sequence in the internal ribosome entry site A (IRES-A) with a Kd of 0.928 μM, therefore destabilizes the G-quadruplex structure, , also hinders tumor cells migration and represses tumor growth by decreasing VEGF-A protein expression.
  5. GC32927 PF-06459988 PF-06459988是T790M-ContainingEGFRMutants不可逆性抑制剂。
  6. GC32915 Pemigatinib

    培米加替尼,INCB054828

    An FGFR inhibitor
  7. GC32875 AZM475271 (M475271)

    M475271

    An inhibitor of c-Src kinase
  8. GC32867 Flumatinib (HHGV678)

    4-[(4-甲基-1-哌嗪基)甲基]-N-[6-甲基-5-[[4-(3-吡啶基)-2-嘧啶基]氨基]-3-吡啶基]-3-(三氟甲基)苯甲酰胺,HHGV678

    A Bcr-Abl inhibitor
  9. GC32864 Ensartinib hydrochloride (X-396 hydrochloride)

    X-396 dihydrochloride

    An ALK inhibitor
  10. GC32836 Naquotinib mesylate (ASP8273)

    ASP8273 (mesylate)

    An irreversible inhibitor of mutant EGFRs
  11. GC32835 PP58

    PP58是吡啶[2,3-d]嘧啶化合物,抑制PDGFR,FGFR和Src家族活性的IC50值在纳摩尔级。

  12. GC32825 eCF506 An inhibitor of Src kinases
  13. GC32819 Mirk-IN-1 (Dyrk1B/A-IN-1)

    Dyrk1B/A-IN-1

    Mirk-IN-1 (Dyrk1B/A-IN-1) 是一种有效的 Dyrk1B(Mirk kianse) 和 Dyrk1A 抑制剂,IC50 分别为 68±48 nM 和 22±8 nM。
  14. GC32808 Selitrectinib (LOXO-195)

    LOXO-195

    A Trk kinase inhibitor
  15. GC32805 Sulfatinib (HMPL-012)

    5-羟基-2-甲基吲哚,HMPL-012

    A multi-kinase inhibitor
  16. GC32802 PRN1371 An irreversible pan-FGFR inhibitor
  17. GC32797 AD80 AD80, a multikinase inhibitor, shows strong activity against human RET (c-RET), BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM.
  18. GC32769 MRX-2843 (UNC2371)

    UNC2371

    A Mer and FLT3 inhibitor
  19. GC32760 Dovitinib lactate (CHIR-258 lactate)

    多韦替尼乳酸盐; CHIR-258 lactate; TKI-258 lactate

    A multi-kinase inhibitor
  20. GC32752 TAS6417

    TAS6417; CLN-081

    TAS6417 (CLN-081, TPC-064) is a novel EGFR inhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. IC50 values ranges from 1.1 ± 0.1 to 8.0 ± 1.1 nmol/L.
  21. GC32748 CA-4948 An IRAK-4 inhibitor
  22. GC32733 Pyrotinib (SHR-1258)

    吡咯替尼; SHR-1258

    Pyrotinib (SHR-1258) (SHR-1258) 是一种有效的选择性 EGFR/HER2 双重抑制剂,IC50 分别为 13 和 38 nM。
  23. GC32731 OSU-T315 (ILK-IN-1)

    OSU-T315 analog

    An ILK inhibitor
  24. GC32726 Tucatinib (Irbinitinib)

    妥卡替尼,Irbinitinib; ARRY-380; ONT-380

    An inhibitor of HER2
  25. GC32713 Cintirorgon (LYC-55716)

    LYC-55716

    A ROR? agonist
  26. GC32703 Asciminib (ABL001)

    ABL001

    An allosteric inhibitor of Abl1
  27. GC32625 KDR-in-4

    KDR-in-4

    KDR-in-4 (KDR-in-4) 是一种有效的激酶插入结构域受体 (KDR/VEGFR2) 抑制剂,IC50 为 7 nM。
  28. GC32623 CE-245677 CE-245677是一种有效的,可逆的Tie2和TrkA/B抑制剂,在细胞体系下,IC50值分别为4.7和1nM。
  29. GC32502 Oglufanide (H-Glu-Trp-OH)

    奥谷法奈; H-Glu-Trp-OH; L-Glutamyl-L-tryptophan

    Oglufanide (H-Glu-Trp-OH) (H-Glu-Trp-OH) 是一种从小牛胸腺中分离出来的二肽免疫调节剂。
  30. GC32469 SU5408 (VEGFR2 Kinase Inhibitor I)

    VEGFR2 Kinase Inhibitor I

    A potent, cell-permeable inhibitor of VEGFR2
  31. GC32458 Trapidil (AR-12008)

    唑嘧胺; AR-12008

    An inhibitor of PDGF-induced activity and an antiplatelet agent
  32. GC19772 FLT3-IN-3

    SAN50900

    An FLT3 inhibitor
  33. GC32127 Alofanib (RPT835)

    RPT835

    An allosteric inhibitor of FGFR2
  34. GC32100 Tarloxotinib bromide (TH-4000)

    TH-4000

    Tarloxotinib bromide (TH-4000)是一种不可逆的EGFR/HER2抑制剂前体。
  35. GC32053 GNE-4997 GNE-4997是一种有效且有选择性的ITK/TSK抑制剂。
  36. GC32044 L 601920-0 (Methyl-3β-hydroxycholenate)

    5-胆烯-24-酸-3Β-醇甲酯

    L 601920-0 (Methyl-3β-hydroxycholenate) 是一种从专利 US20110263046 A1 中提取的 ROR γ 调节剂,如图 2 所示。
  37. GC31880 AZD-0284 AZD-0284是核受体RORγ的反向激动剂。在开发用于治疗寻常型斑块状银屑病和呼吸道疾病。
  38. GC31871 GNE-0946 GNE-0946是一个有效且有选择性的RORγ(RORc)拮抗剂,对HEK-293细胞的EC50值为4nM.
  39. GC31842 GENZ-882706 (RA03546849)

    RA03546849

    GENZ-882706 (RA03546849) 是一种有效的集落刺激因子-1 受体 (CSF-1R) 抑制剂,提取自专利 WO 2017015267A1。
  40. GC31819 PRT062607 (P505-15)

    2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-三唑-2-基)苯基]氨基]-5-嘧啶甲酰胺,P505-15; PRT-2607; BIIB-057

    A potent, orally bioavailable Syk inhibitor
  41. GC31816 ZK-261991 ZK-261991是一种可口服的VEGFR酪氨酸酶抑制剂,抑制VEGFR-2活性的IC50值为5nM。
  42. GC31780 Pralsetinib (Blu667)

    普拉替尼; BLU-667

    Pralsetinib (BLU-667, CS 3009, Gavreto) is a highly potent and selective RET (c-RET) inhibitor with an IC50 of 0.4 nM for WT RET. It also demonstrates potent activity (IC50 0.4 nmol/L) against common oncogenic RET alterations, including RET (M918T).

  43. GC31752 Tesevatinib (XL-647)

    XL-647; EXEL-7647; KD-019

    A multi-kinase inhibitor
  44. GC31726 cFMS-IN-2 cFMS-IN-2是一种FMS激酶抑制剂,其IC50值为0.024μM。
  45. GC31724 DDR1-IN-2

    7rh

    DDR1-IN-2 (DDR1-IN-2) 是一种盘状结构域受体 1 (DDR1) 的有效抑制剂,IC50 为 13.1 nM,对 DDR2 的抑制效果也较弱,IC50 为 203 nM。
  46. GC31706 Ginsenoside Rg5

    人参皂甙 Rg5

    A ginsenoside with diverse biological activities
  47. GC31701 RK-24466 (KIN 001-51)

    KIN 001-51

    A selective inhibitor of lymphocyte-specific protein tyrosine kinase
  48. GC31688 IRAK4-IN-1 IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with IC50 of 7 nM.
  49. GC31676 Tavilermide (MIM-D3)

    MIM-D3

    他维勒胺 (MIM-D3) 是 TrkA 的选择性部分激动剂,或神经生长因子 (NGF) 模拟物。
  50. GC31533 Vimirogant (VTP-43742)

    (S)-N-((5-(乙基磺酰基)吡啶-2-基)甲基)-7-异丙基-6-(((1R,4S)-4-(三氟甲基)环己基)甲基)-6,7-二氢-5H-吡咯并[3,4-B]吡啶-3-甲酰胺,VTP-43742

    Vimirogant (VTP-43742) (VTP-43742) 是一种有效的、选择性的和具有口服活性的 RORγt 抑制剂 (Ki=3.5 nM; IC50=17 nM)。
  51. GC31526 Insulin levels modulator Insulinlevelsmodulator可用于治疗糖尿病。

Items 751 to 800 of 1279 total

per page

Set Descending Direction